This $440,000 Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research at Northwestern University to investigate the use of nasally exhaled breath as a novel, non-invasive diagnostic technique for Alzheimer's disease. The project aims to quantify biomarkers associated with Alzheimer's, such as tau and beta-amyloid proteins, in nasally and orally exhaled breath samples from Alzheimer's patients, healthy older adults, and healthy young adults. If successful, this research could lead to the development of an inexpensive, accessible at-home testing method for Alzheimer's and other neurological diseases. The award runs from December 2024 through November 2026.
Generated 3/4/25, 7:48 AM